Bayer plans $2.2bn pharmaceutical manufacturing facility in Ohio, US

Bayer has announced plans to invest $2.2bn in a new pharmaceutical manufacturing facility in Ohio, US. The investment adds to more than $7bn spent by Bayer on research, development, and manufacturing in the US. Illustration of New Albany International Business Park. Credit: Bayer AG. Bayer has announced plans to invest $2.2bn in a new pharmaceutical manufacturing facility in Ohio, US. The facility will be constructed in the New Albany International Business Park. China Contract Manufacturing Market Outlook Trends, Ambitions, Ke... Reports Greece Healthcare (Pharma and Medical Devices) Market Analysis, Reg... Go deeper with GlobalData The gold standard of business…

Source: Pharmaceutical Technology